The POWER BARIATRIC Trial: Physical Outcomes With Exercise Regimens on BARIATRIC Patients
POWER
1 other identifier
interventional
60
1 country
1
Brief Summary
This study aims to determine how different types of exercise regimens (resistance, aerobic, or combined exercise regimens) can be used to minimize muscle loss and mobilize body fat in severely obese patients after bariatric surgery (BS), despite the rapid surgery-induced weight loss. Additionally, the study will examine how changes in the intestinal microbiota following BS act as a mediation factor that alter tissue-specific responses in muscle and adipose tissue. The study will also evaluate the effect of different types of exercise regimens on cardiometabolic markers, endocrine response, and physical function following BS. Sixty sedentary (regular exercise \<1 hour per week) candidates to bariatric surgery at Herzliya Medical Center will be recruited to participate in this six-month-long randomized control study. Participants will be randomly assigned to either one of three exercise regimens intervention groups (aerobic, resistance, or a combined exercise regimen combining aerobic and resistance exercises) or a control group that will receive standard care. Training will be supervised and matched for metabolic equivalent (METs). The intervention will take place at the Sylvan Adams Sports Institute at Tel Aviv University and an online platform. All measurements will be taken at a presurgical baseline assessment and throughout the study, and will include changes of muscle mass and adipose tissue distribution, measured by a 3-Tesla magnetic resonance imaging (MRI); body composition- will be assessed using multichannel bioelectrical impedance (Seca); Bone mass, will be measured by a Dual-energy X-ray absorptiometry (DEXA); microbiota composition and changes will be evaluated by stool samples that will be subjected to 16S ribosomal ribonucleic acid (16s rRNA) profiling and metagenomics analysis; fasting blood samples will be used to examine endocrine control and cardiometabolic markers; anthropometric measurements to assess surgery results associations with physical activity outcomes and physical function will be assessed by several validated performance assessments, including handgrip, six-minute walk, sit-to-stand, maximum voluntary contraction, and maximal oxygen consumption (VO2max).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Aug 2021
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 8, 2021
CompletedFirst Posted
Study publicly available on registry
March 2, 2021
CompletedStudy Start
First participant enrolled
August 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedOctober 27, 2023
October 1, 2023
3.2 years
February 8, 2021
October 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Muscle mass (cm3)
Changes in thigh muscles volume
At baseline and after 26 weeks of intervention
Body composition - fat mass
Fat mass (Kg)
At baseline and after 13 and 26 weeks of intervention
Body composition
Fat free mass (Kg)
At baseline and after 13 and 26 weeks of intervention
Secondary Outcomes (16)
Microbial composition and changes
At baseline and after 13 and 26 weeks of intervention
Blood measurements - cardiometabolic markers
At baseline and after 13 and 26 weeks of intervention
Blood measurements - Insulin
At baseline and after 13 and 26 weeks of intervention
Blood measurements for skeletal muscle metabolism assessment
At baseline and after 13 and 26 weeks of intervention
Blood measurements - Inflammatory markers
At baseline and after 13 and 26 weeks of intervention
- +11 more secondary outcomes
Other Outcomes (6)
Quality of life (QoL)
At baseline and after 13 and 26 weeks of intervention
Physical function - 6 min walk test
At baseline and after 13 and 26 weeks of intervention
Physical function - sit to stand test
At baseline and after 13 and 26 weeks of intervention
- +3 more other outcomes
Study Arms (4)
Aerobic exercise training
EXPERIMENTALThe aerobic exercise training group, weeks 5-8 after surgery: this training will consist of 30 min. of walking, 3 times per week at an intensity of 60-70% of peak VO2 or RPE 6-7 on the Borg scale. Weeks 9-26 after surgery: this training will consist of 60 minutes of exercise, 3 times per week at an intensity of 65-80% of peak VO2 or RPE 6-8 on the Borg scale. The aerobic exercises will consist of a treadmill or outside walking or running, stationary cycling or elliptical trainer in continuous and interval training.
Resistance exercise training
EXPERIMENTALResistance exercise training group, weeks 5-8 after surgery: this training will consist of 5-10 minutes of warmup, followed by 6-8 multi-joint exercises for major muscle groups, comprising 2 sets of 10 to 25 repetitions at 40% of the one-repetition maximum (1-RM) for each exercise. The intensity will increase on weeks 9-26 after surgery to 8-10 multi-joint exercises of 3-4 sets of 10 to 25 repetitions. For this training participants will use free-weights and body weight exercises.
Combination exercise training
EXPERIMENTALThe combination exercise training will consist of a combined aerobic and resistance exercise training sessions three times weekly. At weeks 5-8 after surgery the sessions will include 5-10 minutes of warmup, followed by 3-4 multi-joint exercises for major muscle groups, comprising 2 sets of 10 to 25 repetitions at 40% of the one-repetition maximum (1-RM) for each exercise. Afterwards the aerobic part of the training will consist of 10-15 minutes of aerobic exercises (treadmill or outside walking or running, stationary cycling or outdoors or elliptical trainer) at 60-70% of peak VO2 or RPE 6-7 at Borg scale. The intensity will increase on weeks 9-26 after surgery to 4-5 multi-joint exercises of 3-4 sets of 10 to 25 repetitions and 30 minutes of aerobic exercises at 65-80% of peak VO2 or RPE 6-8 at Borg scale.
The control group
NO INTERVENTIONThe control group will receive routine health care without exercise supervision (clinical and nutritional follow up).
Interventions
Participants will be randomized into either one of three intervention groups (aerobic training, resistance training, or combined training comprised of resistance and aerobic training) and a control group. Training is described in the arm description section.
Eligibility Criteria
You may qualify if:
- Sedentary participants: regular exercise performed \<1 hour per week
- Candidates for primary bariatric surgery at Herzliya Medical Center in accordance to the National Institutes of Health (NIH) criteria for surgery: (body mass index (BMI) \> 40 without coexisting co-morbidities or BMI \> 35 with \> 1 severe obesity-related comorbidities)
- Sex: all
- Age: 18 to 65 years.
You may not qualify if:
- Severe cardiopulmonary disease (e.g., recent myocardial infarction or unstable angina)
- Musculoskeletal or neuromuscular impairments that preclude exercise training
- Cognitive impairments
- Use of drugs that affect bone or muscle metabolism (mainly steroids)
- Patients with previous bariatric surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tel Aviv Universitylead
- Herzliya Medical Centercollaborator
Study Sites (1)
Tel Aviv University
Tel Aviv, Other, 6997801, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yftach Gepner, Ph.D.
Tel Aviv University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Gepner Yftach
Study Record Dates
First Submitted
February 8, 2021
First Posted
March 2, 2021
Study Start
August 1, 2021
Primary Completion
October 30, 2024
Study Completion
October 30, 2024
Last Updated
October 27, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share